Target intelligence / Profile preview

Transmembrane protein 238 (TMEM238)

Target
TMEM238
Molecular classification
Transmembrane protein, Integral membrane protein
01

Overview

Transmembrane protein 238 (TMEM238) is an integral membrane protein encoded by the TMEM238 gene on chromosome 19q13.42 in humans[2][3]. It is predicted to contain two transmembrane domains, with expression most highly detected in the stomach and colon, and lower but variable levels throughout other tissues[2]. The protein is composed of 176 amino acids and localizes to the plasma membrane based on its structural properties[2][3]. While annotated as potentially participating in amino acid transport and membrane structure, no definitive biochemical function has been confirmed in human studies[2]. Some literature links this gene to Bardet-Biedl Syndrome 2, and gene expression data suggest possible roles in certain conditions (asthma, POEMS syndrome, low-invasive breast cancer), though no mechanistic connection is currently established[2]. Functional studies in mice suggest a related protein (SPESP1) may be involved in sperm function and fertility, but clear direct annotation of this function to human TMEM238 is lacking[1]. There are no known drugs, diagnostic, or therapeutic applications directly targeting TMEM238 at this time[5].

Other names
Transmembrane protein 238TMEM238
02

Mechanism of action

Not applicable (no drugs known to directly target TMEM238)

03

Biological functions

Predicted amino acid transportPossibly involved in sperm function and fertilization (if annotations referring to SPESP1 in mouse are correctly mapped, which is not fully established for human TMEM238)Integral component of the membrane (structural role)
04

Disease associations

Associated with Bardet-Biedl Syndrome 2Upregulated in some disease states (asthma, low-invasive breast cancer, POEMS syndrome)Suggested involvement in developmental metabolic phenotypes following BPA exposure (via methylation)No established direct causative or therapeutic role in major disease classes

Beyond the preview

Go deeper on Transmembrane protein 238 (TMEM238).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 238 (TMEM238).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call